GSK_ Annual_Report_2021-22

141 Notes to the Standalone Financial Statements for the year ended March 31, 2022 Note 37 : Other expenses ( ` in lakhs) Year ended March 31, 2022 Year ended March 31, 2021 Sales promotion 128,32.65 67,37.17 Stock point commission 20,94.98 19,87.26 Freight 50,94.92 37,48.93 Travelling 54,58.91 46,88.44 Loss on disposal of Property, Plant and Equipment (net) - 5.88 Exchange loss (net) 5,13.56 - Manufacturing charges 93,46.30 81,96.22 Repairs: Buildings 9,25.39 11,80.57 Plant and Machinery 12,76.75 13,71.55 22,02.14 25,52.12 Consumption of stores and spares 4,65.55 3,10.36 Power, fuel and water 27,83.23 26,07.72 Rent 1,81.29 2,09.72 Rates and taxes 27,57.32 37,84.38 Printing, postage and telephones 11,52.82 9,27.57 Sales training, briefing and conference 4,46.62 91.92 Insurance 5,35.41 5,43.99 Remuneration to auditors : Statutory audit fees 1,12.00 1,00.00 In other capacity in respect of : Tax audit fees 7.00 7.00 Other services 2.50 2.50 Reimbursement of expenses - 1.24 1,21.50 1,10.74 Cost audit fees 5.70 5.92 Corporate social responsibility (Refer Note 39) 11,91.05 10,32.99 Commission to non whole-time Directors 95.00 1,43.06 Directors' sitting fees 47.50 49.00 Legal and professional fees 35,96.56 11,72.13 Miscellaneous 46,48.24 68,12.13 555,71.25 457,17.65 Note 38 : The recurring expenditure on research and development charged off to statement of profit and loss amounts to ` 1,82.85 lakhs (Previous Year: ` 1,80.72 lakhs).